These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

498 related items for PubMed ID: 27393080

  • 21. No interacting influence of lavender oil preparation silexan on oral contraception using an ethinyl estradiol/levonorgestrel combination.
    Heger-Mahn D, Pabst G, Dienel A, Schläfke S, Klipping C.
    Drugs R D; 2014 Dec; 14(4):265-72. PubMed ID: 25319228
    [Abstract] [Full Text] [Related]

  • 22. Ovulatory effects of three oral contraceptive regimens: a randomized, open-label, descriptive trial.
    Seidman L, Kroll R, Howard B, Ricciotti N, Hsieh J, Weiss H.
    Contraception; 2015 Jun; 91(6):495-502. PubMed ID: 25746294
    [Abstract] [Full Text] [Related]

  • 23. Serum total and unbound testosterone and sex hormone binding globulin (SHBG) in female acne patients treated with two different oral contraceptives.
    Palatsi R, Hirvensalo E, Liukko P, Malmiharju T, Mattila L, Riihiluoma P, Ylöstalo P.
    Acta Derm Venereol; 1984 Jun; 64(6):517-23. PubMed ID: 6084924
    [Abstract] [Full Text] [Related]

  • 24. Effects of a monophasic combined oral contraceptive containing nomegestrol acetate and 17β-oestradiol in comparison to one containing levonorgestrel and ethinylestradiol on markers of endocrine function.
    Ågren UM, Anttila M, Mäenpää-Liukko K, Rantala ML, Rautiainen H, Sommer WF, Mommers E.
    Eur J Contracept Reprod Health Care; 2011 Dec; 16(6):458-67. PubMed ID: 21942708
    [Abstract] [Full Text] [Related]

  • 25. A pharmacokinetic study with a low-dose oral contraceptive containing 20 microg ethinylestradiol plus 100 microg levonorgestrel.
    Endrikat J, Blode H, Gerlinger C, Rosenbaum P, Kuhnz W.
    Eur J Contracept Reprod Health Care; 2002 Jun; 7(2):79-90. PubMed ID: 12201326
    [Abstract] [Full Text] [Related]

  • 26. Evaluation of different antiandrogenic progestins on clinical and biochemical variables in polycystic ovary syndrome.
    Morgante G, Cappelli V, Troìa L, De Leo V.
    Eur J Contracept Reprod Health Care; 2020 Jun; 25(3):176-181. PubMed ID: 32191532
    [Abstract] [Full Text] [Related]

  • 27. A multicentre, open-label, randomised phase III study comparing a new levonorgestrel intrauterine contraceptive system (LNG-IUS 8) with combined oral contraception in young women of reproductive age.
    Borgatta L, Buhling KJ, Rybowski S, Roth K, Rosen K.
    Eur J Contracept Reprod Health Care; 2016 Oct; 21(5):372-9. PubMed ID: 27494570
    [Abstract] [Full Text] [Related]

  • 28. Metabolic and haemostatic effects of estradiol valerate/dienogest, a novel oral contraceptive: a randomized, open-label, single-centre study.
    Junge W, Mellinger U, Parke S, Serrani M.
    Clin Drug Investig; 2011 Oct; 31(8):573-584. PubMed ID: 21721593
    [Abstract] [Full Text] [Related]

  • 29. Change to either a nonandrogenic or androgenic progestin-containing oral contraceptive preparation is associated with improved sexual function in women with oral contraceptive-associated sexual dysfunction.
    Davis SR, Bitzer J, Giraldi A, Palacios S, Parke S, Serrani M, Mellinger U, Nappi RE.
    J Sex Med; 2013 Dec; 10(12):3069-79. PubMed ID: 24034466
    [Abstract] [Full Text] [Related]

  • 30. Pooled analysis of two randomized, open-label studies comparing the effects of nomegestrol acetate/17β-estradiol and drospirenone/ethinyl estradiol on bleeding patterns in healthy women.
    Mansour D, Westhoff C, Kher U, Korver T.
    Contraception; 2017 Apr; 95(4):390-397. PubMed ID: 28011288
    [Abstract] [Full Text] [Related]

  • 31. Unique effects on hepatic function, lipid metabolism, bone and growth endocrine parameters of estetrol in combined oral contraceptives.
    Mawet M, Maillard C, Klipping C, Zimmerman Y, Foidart JM, Coelingh Bennink HJ.
    Eur J Contracept Reprod Health Care; 2015 Apr; 20(6):463-75. PubMed ID: 26212489
    [Abstract] [Full Text] [Related]

  • 32. Bleeding pattern and cycle control with an estradiol-based oral contraceptive: a seven-cycle, randomized comparative trial of estradiol valerate/dienogest and ethinyl estradiol/levonorgestrel.
    Ahrendt HJ, Makalová D, Parke S, Mellinger U, Mansour D.
    Contraception; 2009 Nov; 80(5):436-44. PubMed ID: 19835717
    [Abstract] [Full Text] [Related]

  • 33. Efficacy and safety of the combined oral contraceptive ethinylestradiol/drospirenone (Yasmin) in healthy Chinese women: a randomized, open-label, controlled, multicentre trial.
    Guang-Sheng F, Mei-Lu B, Li-Nan C, Xiao-Ming C, Zi-Rong H, Zi-Yan H, Xiao-Ping J, Jian L, Shu-Ying W, Cheng-Liang X, Zheng-Ai X, Tian-Fu Y.
    Clin Drug Investig; 2010 Nov; 30(6):387-96. PubMed ID: 20201608
    [Abstract] [Full Text] [Related]

  • 34. Lansoprazole does not affect the bioavailability of oral contraceptives.
    Fuchs W, Sennewald R, Klotz U.
    Br J Clin Pharmacol; 1994 Oct; 38(4):376-80. PubMed ID: 7833230
    [Abstract] [Full Text] [Related]

  • 35. The effects of oral contraceptives on androgen levels and their relevance to premenstrual mood and sexual interest: a comparison of two triphasic formulations containing norgestimate and either 35 or 25 microg of ethinyl estradiol.
    Greco T, Graham CA, Bancroft J, Tanner A, Doll HA.
    Contraception; 2007 Jul; 76(1):8-17. PubMed ID: 17586130
    [Abstract] [Full Text] [Related]

  • 36. Effects of combined oral contraceptives containing levonorgestrel or chlormadinone on the endothelium.
    Franceschini SA, Vieira CS, Martins WP, França JB, Ferriani RA.
    Contraception; 2013 Jun; 87(6):766-72. PubMed ID: 23102798
    [Abstract] [Full Text] [Related]

  • 37. Effects of oral contraceptive combinations containing levonorgestrel or desogestrel on serum proteins and androgen binding.
    Bergink EW, Holma P, Pyörälä T.
    Scand J Clin Lab Invest; 1981 Nov; 41(7):663-8. PubMed ID: 6461916
    [Abstract] [Full Text] [Related]

  • 38. Short-term variations in bone remodeling markers of an oral contraception formulation containing 3 mg of drospirenone plus 30 microg of ethinyl estradiol: observational study in young postadolescent women.
    Paoletti AM, Orrù M, Lello S, Floris S, Ranuzzi F, Etzi R, Zedda P, Guerriero S, Fratta S, Sorge R, Mallarini G, Melis GB.
    Contraception; 2004 Oct; 70(4):293-8. PubMed ID: 15451333
    [Abstract] [Full Text] [Related]

  • 39. Androgens and sexual behaviour in women using oral contraceptives.
    Bancroft J, Davidson DW, Warner P, Tyrer G.
    Clin Endocrinol (Oxf); 1980 Apr; 12(4):327-40. PubMed ID: 6991164
    [Abstract] [Full Text] [Related]

  • 40. Interrelationship of serum levonorgestrel and sex hormone-binding globulin levels following vaginal and oral administration of combined steroid contraceptive tablets.
    Abdalla KA, Shabaan MM, Stanczyk FZ.
    Contraception; 1992 Feb; 45(2):111-8. PubMed ID: 1559334
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.